Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Blind Prospective Parallel Control Group Pilot Study to Assess the Effect of Hylan G-F 20 (Synvisc) Supplementation on Cartilage Preservation in Osteoarthritis of the Knee

NCT00393393 is registered in ClinicalTrials.gov with Cabrini Medical Centre as lead sponsor.

NCT NCT00393393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00393393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Blind Prospective Parallel Control Group Pilot Study to Assess the Effect of Hylan G-F 20 (Synvisc) Supplementation on Cartilage Preservation in Osteoarthritis of the Knee
Lead sponsor
Cabrini Medical Centre
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2006
Completion date
January 31, 2006
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis